It’s 4/20 Day around the world, and in Canada that means both cannabis stocks and the impending rec legalization are on everyone’s mind. But with nine US states plus the District of Columbia having now legalized rec cannabis, Americans are wondering if the Canuck pot stocks are a good investment. Definitely, says Tim Seymour, “Fast […]
The Cantech Letter Cannabis section is brought to you by ABCann Medicinals. Organically grown standardized marijuana. Click on the logo above for more info.
The medical marijuana industry is about to get much bigger, CannTrust CEO says
While all eyes are on the launch date for recreational cannabis in Canada —said to come in either late summer or early fall— the medical side of the equation should be getting the attention, as well, because it’s about to get much bigger, says Eric Paul, CEO of licensed producer CannTrust Holdings (TSX:TRST). The ramp […]
Aurora Cannabis is now a buy, Canaccord Genuity says
With Aurora Cannabis’ (TSX:ACB) newly announced plans to build a 1.2 million sq. ft. greenhouse in Medicine Hat, Alberta, the tally puts ACB’s total production capacity at a eye-popping 430,000 kg annually. That’s a lot of weed, enough to assert the company’s presence both on the domestic and international stages, says analyst Neil Maruoka of […]
CannTrust Holdings is trading at a “remarkable discount”, Ecehlon Wealth says
A pair of new developments have Echelon Wealth Partners analyst Russell Stanley feeling upbeat about marijuana player CannTrust Holdings (TSX:TRST). On Wednesday, CannTrust announced it would launch a range of new cannabis oil vegan-based hard shell capsules. “We are excited to be moving into this new category of the medicinal cannabis market, one that makes […]
Aphria has a 63 per cent upside, GMP Securities says
Aphria Inc’s (TSX:APH) third quarter fiscal 2018 results beat expectations, with an 81 per cent uptick in adjusted EBITDA, but regulatory delays in both Canada and Germany are cause for analyst Martin Landry of GMP Securities to lower his estimates for FY18 and FY19. In a research note to clients on Tuesday, Landry maintained his […]
Canopy Growth Corp. will “swarm the shelves” of the rec cannabis market, Beacon says
Canopy Growth Corp. (TSX:WEED) is poised to produce an incredible 220,000 kg of cannabis by 2020, which would potentially give it one-third of the entire Canadian market, says analyst Vahan Ajamian of Beacon Securities, who on Monday reiterated his “Buy” recommendation and 12-month target price of $37.00 per share for WEED. Last week, Smiths Falls, […]
MPX Bioceutical is undervalued, Echelon Wealth says
A new acquisition has Echelon Wealth Partners analyst Russell Stanley maintaining his bullish stance on MPX Bioceutical Corp. (CSE:MPX). This morning, MPX announced it had signed a letter of intent to acquire Peterborough-based LP Canveda for $3-million in cash, $15-million in stock and warrants. “We have always considered a Canadian presence to be a critical […]
Canopy Growth Corp’s valuation is just too high, Canaccord Genuity says
While Canopy Growth Corp. (TSX:WEED) is the clear industry leader of the cannabis sector, both domestically and internationally, the stock is overvalued, says analyst Neil Maruoka of Canaccord Genuity, who on Sunday reiterated his “Hold” rating and 12-month target price of $26.50. Canopy Growth was busy last week with a number of new announcements: (1) […]
Canopy Growth Corp, Aphria and Aurora will win the marijuana sector, Horizons ETFs VP says
A new survey of investment advisors finds a growing distaste for Canadian stocks —including those in the cannabis sector which have been performing poorly over the past few months. Too bad, says Mark Noble of Horizons ETFs, who claims that with the head start that they’ll have once recreational marijuana is legalized later this year, […]
Marijuana stock CannaRoyalty has 50% upside, Beacon Securities says
A 75 per cent increase in share price over the past nine months doesn’t tell the whole story for cannabis sector investor and operator CannaRoyalty (CSE:CRZ), says analyst Vahan Ajamian of Beacon Securities, who claims that the company’s recent acquisitions drastically improve its financial condition. The analyst resumed coverage on Friday by reiterating his “Buy” […]
- 1
- 2
- 3
- …
- 28
- Next Page »